Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dermata Therapeutics, Inc. (DRMA)
:DRMA
Holding DRMA?
Track your performance easily
DRMA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.00 - $8.66
Previous CloseN/A
Volume28.34K
Average Volume (3M)504.46K
Market Cap
$2.71M
Enterprise Value-$3.59M
Total Cash (Recent Filing)$1.99M
Total Debt (Recent Filing)$553.19K
Price to Earnings (P/E)―
Beta0.95
Next Earnings
Mar 31, 2025EPS Estimate
-1.5Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-21.42
Shares Outstanding2,040,768
10 Day Avg. Volume133,665
30 Day Avg. Volume504,465
Standard Deviation0.22
R-Squared0.02
Alpha-0.14
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.39
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market Cap-1.32
Enterprise Value/Revenue-0.52
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.32
Forecast
1Y Price Target
$6.00Price Target Upside351.13% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Dermata Therapeutics News
PremiumMarket News
3 Penny Stocks to Watch Now, 8/6/24Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.24%
Mutual Funds
1.37% Other Institutional Investors
98.39% Public Companies and Individual Investors
DRMA FAQ
What was Dermata Therapeutics, Inc.’s price range in the past 12 months?
Dermata Therapeutics, Inc. lowest stock price was $1.00 and its highest was $8.65 in the past 12 months.
What is Dermata Therapeutics, Inc.’s market cap?
Dermata Therapeutics, Inc.’s market cap is $2.71M.
When is Dermata Therapeutics, Inc.’s upcoming earnings report date?
Dermata Therapeutics, Inc.’s upcoming earnings report date is Mar 31, 2025 which is in 71 days.
How were Dermata Therapeutics, Inc.’s earnings last quarter?
Dermata Therapeutics, Inc. released its earnings results on Nov 13, 2024. The company reported -$2.04 earnings per share for the quarter, beating the consensus estimate of -$2.64 by $0.6.
Is Dermata Therapeutics, Inc. overvalued?
According to Wall Street analysts Dermata Therapeutics, Inc.’s price is currently Undervalued.
Does Dermata Therapeutics, Inc. pay dividends?
Dermata Therapeutics, Inc. does not currently pay dividends.
What is Dermata Therapeutics, Inc.’s EPS estimate?
Dermata Therapeutics, Inc.’s EPS estimate is -1.5.
How many shares outstanding does Dermata Therapeutics, Inc. have?
Dermata Therapeutics, Inc. has 2,040,768 shares outstanding.
What happened to Dermata Therapeutics, Inc.’s price movement after its last earnings report?
Dermata Therapeutics, Inc. reported an EPS of -$2.04 in its last earnings report, beating expectations of -$2.64. Following the earnings report the stock price went down -3.252%.
Which hedge fund is a major shareholder of Dermata Therapeutics, Inc.?
Currently, no hedge funds are holding shares in DRMA
---
Company Description
Dermata Therapeutics, Inc.
Dermata Therapeutics Inc is a clinical-stage biotechnology company. It is focused on the treatment of multiple medical and aesthetic skin conditions and diseases with high unmet needs.
---
DRMA Stock 12 Month Forecast
Average Price Target
$6.00
▲(351.13% Upside)
Technical Analysis
Hoth Therapeutics
―
SELLAS Life Sciences Group
―
Regulus
―
Heron Therapeutics
―
Kala Pharmaceuticals
―
Best Analysts Covering DRMA
1 Year
1 Year Success Rate
1/16 ratings generated profit
1 Year Average Return
-73.83%
reiterated a buy rating 2 months ago
Copying Anthony Vendetti's trades and holding each position for 1 Year would result in 6.25% of your transactions generating a profit, with an average return of -73.83% per trade.
---